Want to see NUVB full AI Analyst Report?
Nuvation Bio (NUVB) Ratios
927 Followers
Nuvation Bio Ratios
NUVB's free cash flow for Q3 2026 was $-40.15M. For the 2026 fiscal year, NUVB's free cash flow was decreased by $-1.59M and operating cash flow was $-38.56M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.95 | 9.04 | 44.11 | 50.70 | 45.62 |
| Quick Ratio | 6.81 | 9.04 | 44.11 | 50.70 | 45.62 |
| Cash Ratio | 2.00 | 0.61 | 3.05 | 7.68 | 7.82 |
| Solvency Ratio | -0.70 | -7.38 | -4.62 | -6.09 | -2.87 |
| Operating Cash Flow Ratio | -2.11 | -2.24 | -4.87 | -7.30 | -4.03 |
| Short-Term Operating Cash Flow Coverage | -22.81 | -20.76 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 282.41M | $ 449.42M | $ 600.07M | $ 650.25M | $ 741.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.95 | 1.17 | 1.03 | 1.03 | 1.04 |
| Debt Service Coverage Ratio | -8.89 | -85.58 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -15.57 | -1737.91 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.07 | 0.03 | 0.02 | 0.02 | 0.02 |
| Net Debt to EBITDA | 0.81 | 0.05 | 0.51 | 0.81 | 1.39 |
| Profitability Margins | |||||
| Gross Profit Margin | 86.58% | 10.10% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -303.56% | -7209.42% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -300.79% | -7200.75% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -338.72% | -7527.33% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -325.31% | -7213.76% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -325.31% | -7213.76% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -325.31% | -7213.76% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 96.04% | 95.83% | 75.94% | 87.03% | 93.07% |
| Return on Assets (ROA) | -34.40% | -105.05% | -12.20% | -15.50% | -11.19% |
| Return on Equity (ROE) | -66.93% | -122.46% | -12.53% | -15.91% | -11.64% |
| Return on Capital Employed (ROCE) | -41.57% | -122.85% | -16.43% | -18.17% | -12.29% |
| Return on Invested Capital (ROIC) | -40.96% | -120.86% | -16.38% | -18.14% | -12.28% |
| Return on Tangible Assets | -35.06% | -105.96% | -12.20% | -15.50% | -11.19% |
| Earnings Yield | -6.69% | -79.44% | -22.93% | -25.04% | -5.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.25 | 0.48 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.89 | 1.11 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 14.03 | 2.63 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.11 | 0.01 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.13 | 0.01 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 195.88 | 427.96 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 112.35 | 755.31 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 493.37 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 409.84 | 327.36 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 605.71 | 755.31 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.51 | -0.49 | -0.31 | -0.44 | -0.34 |
| Free Cash Flow Per Share | -0.51 | -0.49 | -0.31 | -0.45 | -0.35 |
| Dividend Paid and CapEx Coverage Ratio | -489.91 | -805.02 | -985.49 | -259.75 | -241.81 |
| Capital Expenditure Coverage Ratio | -489.91 | -805.02 | -985.49 | -259.75 | -241.81 |
| Operating Cash Flow Coverage Ratio | -17.09 | -14.63 | -16.97 | -22.56 | -22.32 |
| Operating Cash Flow to Sales Ratio | -2.76 | -16.56 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -5.68% | -18.26% | -20.59% | -23.19% | -4.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.93 | -1.26 | -4.36 | -3.99 | -19.37 |
| Price-to-Sales (P/S) Ratio | 48.65 | 90.81 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 10.01 | 1.54 | 0.55 | 0.64 | 2.25 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.61 | -5.48 | -4.86 | -4.31 | -24.57 |
| Price-to-Operating Cash Flow Ratio | -17.65 | -5.48 | -4.86 | -4.33 | -24.67 |
| Price-to-Earnings Growth (PEG) Ratio | 0.21 | -0.00 | 0.16 | -0.44 | -0.15 |
| Enterprise Value Multiple | -15.36 | -1.21 | -3.86 | -2.67 | -16.67 |
| Enterprise Value | 2.91B | 688.13M | 291.87M | 319.27M | 1.55B |
| EV to EBITDA | -15.36 | -1.21 | -3.86 | -2.67 | -16.67 |
| EV to Sales | 46.20 | 87.40 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -16.72 | -5.27 | -4.29 | -3.31 | -22.68 |
| EV to Operating Cash Flow | -16.76 | -5.28 | -4.29 | -3.32 | -22.77 |
| Tangible Book Value Per Share | 0.86 | 1.71 | 2.76 | 3.02 | 3.77 |
| Shareholders’ Equity Per Share | 0.90 | 1.73 | 2.76 | 3.02 | 3.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.18 | 0.03 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.07 | 1.00 | 1.00 | 0.87 | 0.93 |
| Research & Development to Revenue | 1.83 | 66.58 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 2.41 | 8.79 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.57 | 4.10 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.85 | 0.23 | 0.90 | 0.92 | 0.79 |
Currency in USD
